These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 24867136

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of ¹³¹I therapy and correlation factors of Graves' disease patients: a 4-year retrospective study.
    Zheng W, Jian T, Guizhi Z, Zhaowei M, Renfei W.
    Nucl Med Commun; 2012 Jan; 33(1):97-101. PubMed ID: 22008631
    [Abstract] [Full Text] [Related]

  • 3. Hepatic dysfunction related to thyrotropin receptor antibody in patients with Graves' disease.
    He K, Hu Y, Xu XH, Mao XM.
    Exp Clin Endocrinol Diabetes; 2014 Jun; 122(6):368-72. PubMed ID: 24941434
    [Abstract] [Full Text] [Related]

  • 4. Decreased serum level of IL-7 in patients with active Graves' disease.
    Motylewska E, Nieć M, Siejka A, Komorowski J, Ławnicka H, Świętosławski J, Stępień H.
    Cytokine; 2015 Oct; 75(2):373-9. PubMed ID: 26113403
    [Abstract] [Full Text] [Related]

  • 5. Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment.
    Wang R, Tan J, Zhang G, Zheng W, Li C.
    Medicine (Baltimore); 2017 Feb; 96(5):e6035. PubMed ID: 28151911
    [Abstract] [Full Text] [Related]

  • 6. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W, Man N, Li YS, Shan ZY, Teng WP.
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [Abstract] [Full Text] [Related]

  • 7. Establishment of clinical diagnosis model of Graves' disease and Hashimoto's thyroiditis.
    Cui Z, Wang Z, Liu X, Cai Y, Xu X, Yang T.
    J Transl Med; 2019 Jan 07; 17(1):11. PubMed ID: 30616573
    [Abstract] [Full Text] [Related]

  • 8. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
    Yuan S, Yu N, Gao Y, Huang W, He Y, Dong B, Lu G, Li M, Cai X, Peng D, Wang Y, Li T, Huang Y, Gao Y, Guo X, Shi B.
    Zhonghua Yi Xue Za Zhi; 2014 Jan 14; 94(2):110-4. PubMed ID: 24721350
    [Abstract] [Full Text] [Related]

  • 9. Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy.
    Choi YM, Kwak MK, Hong SM, Hong EG.
    Endocrinol Metab (Seoul); 2019 Sep 14; 34(3):268-274. PubMed ID: 31565879
    [Abstract] [Full Text] [Related]

  • 10. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y.
    J Clin Endocrinol Metab; 2000 Nov 14; 85(11):4157-61. PubMed ID: 11095447
    [Abstract] [Full Text] [Related]

  • 11. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M, Koizumi Y, Aizawa T, Yamada T, Takahashi Y, Watanabe T, Kamoi K.
    J Clin Endocrinol Metab; 1988 Jan 14; 66(1):103-8. PubMed ID: 3121661
    [Abstract] [Full Text] [Related]

  • 12. The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.
    Tagami T, Hagiwara H, Kimura T, Usui T, Shimatsu A, Naruse M.
    Thyroid; 2007 Aug 14; 17(8):767-72. PubMed ID: 17651013
    [Abstract] [Full Text] [Related]

  • 13. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
    Hu YM, Liu W, Lu GH.
    Zhonghua Yi Xue Za Zhi; 2003 Jun 10; 83(11):940-2. PubMed ID: 12899792
    [Abstract] [Full Text] [Related]

  • 14. [Thyroid hormone changes in women with pre-eclampsia and its relationship with the presence of pre-eclampsia].
    Zhou J, Du J, Ma B, Liu X, Qiu H, Li J, Wang X.
    Zhonghua Fu Chan Ke Za Zhi; 2014 Feb 10; 49(2):109-13. PubMed ID: 24739642
    [Abstract] [Full Text] [Related]

  • 15. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC, Ingbar SH.
    J Clin Invest; 1979 Nov 10; 64(5):1429-36. PubMed ID: 91625
    [Abstract] [Full Text] [Related]

  • 16. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG.
    Clin Endocrinol (Oxf); 2004 Nov 10; 61(5):612-8. PubMed ID: 15521965
    [Abstract] [Full Text] [Related]

  • 17. The effect of radioiodine treatment on the characteristics of TRAb in Graves' disease.
    Fang Y, Du WH, Zhang CX, Zhao SX, Song HD, Gao GQ, Dong M.
    BMC Endocr Disord; 2021 Nov 30; 21(1):238. PubMed ID: 34847904
    [Abstract] [Full Text] [Related]

  • 18. Low Vitamin D Status is Associated with Increased Thyrotropin-Receptor Antibody Titer in Graves Disease.
    Zhang H, Liang L, Xie Z.
    Endocr Pract; 2015 Mar 30; 21(3):258-63. PubMed ID: 25370319
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
    Uenaka M, Tanimura K, Tairaku S, Morioka I, Ebina Y, Yamada H.
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun 30; 177():89-93. PubMed ID: 24726178
    [Abstract] [Full Text] [Related]

  • 20. Impact of thyrotropin receptor antibody levels on fetal development in two successive pregnancies in a woman with Graves' disease.
    Bjørgaas MR, Farstad H, Christiansen SC, Blaas HG.
    Horm Res Paediatr; 2013 Jun 30; 79(1):39-43. PubMed ID: 23154300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.